ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
Pharmacol Res
; 108: 111-118, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-27137881
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptor, ErbB-2
/
Polymorphism, Single Nucleotide
/
Trastuzumab
/
Antineoplastic Agents, Immunological
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2016
Document type:
Article
Country of publication: